CANC Holdings Information

CANC is an equity ETF with a total of 56 individual holdings. The top holdings are Revolution Medicines stock at 7.09%, Eli Lilly and Company at 5.62%, BridgeBio Pharma at 4.38%, Roche Holding AG at 3.93%, and Genmab at 3.91%.

Total Holdings

Top 10 Percentage

42.83%

Asset Class

Equity

ETF Category

Health

Assets

85.97M

PE Ratio

20.39

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	7.09%	102,671
2	LLY	Eli Lilly and Company	5.62%	5,389
3	BBIO	BridgeBio Pharma, Inc.	4.38%	60,810
4	RHHBY	Roche Holding AG	3.93%	84,197
5	GMAB	Genmab A/S	3.91%	117,021
6	SWX: NOVN	Novartis AG	3.87%	27,035
7	LON: AZN	AstraZeneca PLC	3.86%	20,437
8	ACLX	Arcellx, Inc.	3.71%	37,071
9	NUVL	Nuvalent, Inc.	3.60%	33,243
10	EXEL	Exelixis, Inc.	2.86%	64,604
11	IDYA	IDEAYA Biosciences, Inc.	2.73%	74,801
12	ABBV	AbbVie Inc.	2.61%	10,573
13	BMY	Bristol-Myers Squibb Company	2.58%	48,206
14	ONC	BeOne Medicines AG	2.47%	6,819
15	MRUS	Merus N.V.	2.42%	21,977
16	CELC	Celcuity Inc.	2.27%	25,974
17	IMNM	Immunome, Inc.	2.25%	113,669
18	JNJ	Johnson & Johnson	2.22%	10,270
19	LEGN	Legend Biotech Corporation	2.05%	54,933
20	SNDX	Syndax Pharmaceuticals, Inc.	2.01%	125,795
21	ZLAB	Zai Lab Limited	1.94%	62,511
22	GILD	Gilead Sciences, Inc.	1.84%	12,939
23	AMGN	Amgen Inc.	1.78%	5,152
24	SMMT	Summit Therapeutics Inc.	1.71%	80,858
25	COGT	Cogent Biosciences, Inc.	1.63%	90,567

Showing 25 of 56 holdings

Subscribe to see the full list

Activate Now

As of Nov 3, 2025